Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Insulet Corporation stock logo
PODD
Insulet
$161.28
+1.9%
$152.93
$138.79
$354.88
$11.17B1.111.36 million shs723,321 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Insulet Corporation stock logo
PODD
Insulet
+1.89%-1.95%+7.01%-18.10%-45.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Insulet Corporation stock logo
PODD
Insulet
$161.28
+1.9%
$152.93
$138.79
$354.88
$11.17B1.111.36 million shs723,321 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Insulet Corporation stock logo
PODD
Insulet
+1.89%-1.95%+7.01%-18.10%-45.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Insulet Corporation stock logo
PODD
Insulet
2.71
Moderate Buy$237.0847.00% Upside

Current Analyst Ratings Breakdown

Latest PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetBuy$250.00 ➝ $225.00
7/8/2026
Insulet Corporation stock logo
PODD
Insulet
Boost Price TargetNeutral$165.00 ➝ $172.00
7/6/2026
Insulet Corporation stock logo
PODD
Insulet
Set Price Target$180.00
6/24/2026
Insulet Corporation stock logo
PODD
Insulet
DowngradeHold (C-)Sell (D+)
6/23/2026
Insulet Corporation stock logo
PODD
Insulet
Initiated CoverageBuy$190.00
6/11/2026
Insulet Corporation stock logo
PODD
Insulet
Set Price Target$219.00
6/11/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetBuy$250.00 ➝ $219.00
6/8/2026
Insulet Corporation stock logo
PODD
Insulet
Set Price Target$216.00
6/1/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetHold$379.00 ➝ $294.00
5/28/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetNeutral$175.00 ➝ $165.00
(Data available from 7/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Insulet Corporation stock logo
PODD
Insulet
$2.71B4.12$6.32 per share25.51$21.54 per share7.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Insulet Corporation stock logo
PODD
Insulet
$247.10M$4.3037.5120.081.1210.44%26.87%12.01%8/5/2026 (Confirmed)

Latest PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Insulet Corporation stock logo
PODD
Insulet
$1.45N/AN/AN/A$787.82 millionN/A
5/6/2026Q1 2026
Insulet Corporation stock logo
PODD
Insulet
$1.19$1.42+$0.23$1.30$729.89 million$761.70 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Insulet Corporation stock logo
PODD
Insulet
0.71
2.49
1.81

Institutional Ownership

CompanyInstitutional Ownership
Insulet Corporation stock logo
PODD
Insulet
N/A

Insider Ownership

CompanyInsider Ownership
Insulet Corporation stock logo
PODD
Insulet
0.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.26 million69.02 millionOptionable

Recent News About These Companies

Citi Sticks to Their Hold Rating for Insulet (PODD)
Swedbank AB Cuts Position in Insulet Corporation $PODD
Insulet (PODD) Launches Omnipod 5 In Spain, Is The Stock Cheap?
Here's Why Insulet (PODD) is a Strong Growth Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Insulet stock logo

Insulet NASDAQ:PODD

$161.28 +2.99 (+1.89%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$161.46 +0.18 (+0.11%)
As of 07/10/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.